eMark suggested I repost this as a new thread - see below. Might...

eMark suggested I repost this as a new thread - see below. Might also be good for others to post summaries from analysts and commentators for all to see.

_____________________________
Probably most have seen the Bell Potter report yesterday. But in case some have missed it, they still are hopeful, despite a heavy downgrade. An excerpt:

"Our new target price is $1.10 (was $3.30). We see the potential for a re-rating coming out of the company’s advice from the FDA in August 2012."

It's going to be a very tense 2 months wait but good luck to holders.
_____________________________